TNF and rheumatic disorder: Case studies have suggested that patients on anti-TNF therapy for rheumatic diseases tend to have lower hospitalization rates from COVID-19 [188], suggesting a prophylactic effect of anti-TNF therapy in the disease pathogenesis.